CFF Investing Up to $110M, Partnering to Advance Gene Therapy

CFF Investing Up to $110M, Partnering to Advance Gene Therapy

311300

CFF Investing Up to $110M, Partnering to Advance Gene Therapy

The Cystic Fibrosis Foundation (CFF) is partnering with Pioneering Medicines, an initiative of Flagship Pioneering, to support the development of various types of gene therapy for cystic fibrosis (CF). The foundation is ready to invest up to $110 million to move therapy candidates into clinical testing, starting with an initial $20 million investment. As part of the collaboration, CFF also has the option of making extra money available as promising therapies are developed. “We will not rest until…

You must be logged in to read/download the full post.